Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Journal of Virus Eradication|February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected childrenP Palma, C Foster, P Rojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2011
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitorXuesong Liu, Yan Shi, David X Maag, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2012
Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinasesMichael L Curtin, H Robin Heyman, Robin R Frey, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2013
Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance studyGloria M González, Rogelio de J Treviño-Rangel, José P Palma-Nicolás, et al.
Anticancer Research|November 28, 2008
The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivoJoann P Palma, Luis E Rodriguez, Velitchka D Bontcheva-Diaz, et al.
Molecular Genetics and Metabolism|February 4, 2018
Prenatal treatment of ornithine transcarbamylase deficiencyYael Wilnai, Yair J Blumenfeld, Kristina Cusmano, et al.
The Journal of Pathology|November 28, 2022
Cell death induced by NLRP3-palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity-tuberculosis comorbiditySandra P Palma Albornoz, Thais Fc Fraga-Silva, Renan Vh de Carvalho, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Characteristics of the National Applicant Pool for Clinical Informatics Fellowships (2016-2017)Douglas S Bell, Kevin Baldwin, Elijah J Bell, et al.
Nature|June 10, 2025
Silicate clouds and a circumplanetary disk in the YSES-1 exoplanet systemK K W Hoch, M Rowland, S Petrus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor modelsCherrie K Donawho, Yan Luo, Yanping Luo, et al.
Pageof 21